Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2024-05-10 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in issued shares, not on financial results, management commentary, or other report types. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document is lengthy and detailed, not a brief announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-05-10 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates, quantities, and prices. The document references compliance with listing rules of the Stock Exchange of Hong Kong and confirms authorization by the board of directors. The content is focused on reporting share repurchase activities and changes in issued shares, which aligns with announcements of transactions in own shares (share buybacks). It is not a full financial report, earnings release, or management discussion, but a regulatory disclosure of share repurchase transactions. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2024-05-09 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in issued shares, not on financial results, management commentary, or other report types. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not just an announcement or a brief summary, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2024-05-08 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchases of shares with dates, quantities, and prices. The document references compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in issued share capital, not on financial results, management commentary, or other report types. It is a regulatory disclosure about share repurchases and capital changes. Therefore, the document fits best under the category 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2024-05-07 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on reporting share repurchase transactions and changes in issued share capital, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not merely an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-05-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return filed by Kindstar Globalgene Technology, Inc. It details changes in issued share capital and share buybacks, including specific dates, number of shares repurchased, and prices paid. The document references compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. It is a regulatory disclosure about share repurchases and capital changes, not a financial report, earnings release, or management discussion. The content fits the description of a Transaction in Own Shares filing, which reports the company's buyback activities and changes in share capital.
2024-05-03 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.